1. Academic Validation
  2. Adenosine interaction with adenosine receptor A2a promotes gastric cancer metastasis by enhancing PI3K-AKT-mTOR signaling

Adenosine interaction with adenosine receptor A2a promotes gastric cancer metastasis by enhancing PI3K-AKT-mTOR signaling

  • Mol Biol Cell. 2019 Sep 1;30(19):2527-2534. doi: 10.1091/mbc.E19-03-0136.
Linsen Shi 1 2 Zhaoying Wu 3 Ji Miao 4 Shangce Du 2 Shichao Ai 5 En Xu 5 Min Feng 4 Jun Song 1 6 Wenxian Guan 2 4
Affiliations

Affiliations

  • 1 Department of Gastrointestinal Surgery, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221006, People's Republic of China.
  • 2 The Affiliated Nanjing Drum Tower Clinical College of Nanjing Medical University, Nanjing 210002, People's Republic of China.
  • 3 Xuzhou Medical University, Xuzhou 221006, People's Republic of China.
  • 4 Department of Gastrointestinal Surgery, The Affiliated Drum Tower Hospital of Nanjing University, Nanjing 210000, People's Republic of China.
  • 5 Nanjing University, Nanjing 21000, People's Republic of China.
  • 6 Institute of Digestive Diseases, Xuzhou Medical University, Xuzhou 221006, People's Republic of China.
Abstract

The accumulation of adenosine in the tumor microenvironment is associated with tumor progression in many cancers. However, whether adenosine is involved in gastric Cancer (GC) metastasis and progression, and the underlying molecular mechanism, is largely unclear. In this study, we find that GC tissues and cell lines had higher A2aR levels than nontumor gastric tissues and cell lines. A2aR expression correlated positively with TNMstage, and associated with poor outcomes. Adenosine enhanced the expression of the stemness and epithelial-mesenchymal transition-associated genes by binding to A2aR. A2aR expression on GC cells promoted metastasis in vivo. The PI3K-AKT-mTOR signaling pathway was involved in adenosine-stimulated GC cell migration and invasion. Our results indicate that adenosine promotes GC cell invasion and metastasis by interacting with A2aR to enhance PI3K-AKT-mTOR pathway signaling.

Figures
Products